These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 4247291)

  • 1. [Kinin derivatives and plasmin].
    Fujii S; Tsutsumi K
    Nihon Ishikai Zasshi; 1970 Apr; 63(7):924-32. PubMed ID: 4247291
    [No Abstract]   [Full Text] [Related]  

  • 2. Contact and plasmin kinin-forming systems in the blood.
    Buluk K; Czokalo M; Malofiejew M
    Thromb Diath Haemorrh; 1970 Dec; 24(3):548-58. PubMed ID: 4251262
    [No Abstract]   [Full Text] [Related]  

  • 3. [Kinin derivatives and allergy].
    Kimura Y
    Nihon Ishikai Zasshi; 1970 Apr; 63(7):941-6. PubMed ID: 4247292
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [On the kinin-forming systems activated by plasmin and activated by the contact factor].
    Buluk K; Malofiejew M; Czokalo M
    Pol Tyg Lek; 1967 Jul; 22(20):1140-2. PubMed ID: 4228805
    [No Abstract]   [Full Text] [Related]  

  • 6. [Characteristics of contact activation of rabbit blood (kallikrein and plasmin systems].
    Komissarova NV; Gomazkov OA
    Biull Eksp Biol Med; 1976; 81(4):390-2. PubMed ID: 132208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on plasma kallikrein and its relationship to plasmin.
    WEBSTER ME; PIERCE JV
    J Pharmacol Exp Ther; 1960 Dec; 130():484-91. PubMed ID: 13783664
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent studies of the synthetic selective inhibitors; with special reference to non-plasmin fibrinolytic enzyme, plasmin and plasma-kallikrein.
    Okamoto S; Okamoto U; Hijikata-Okunomiya A; Wanaka K; Okada Y
    Thromb Res Suppl; 1988; 8():131-41. PubMed ID: 2974647
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of plasmin on the kinin system of rat blood].
    Andreenko GV; Suvorov AV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1975; (4):44-8. PubMed ID: 130169
    [No Abstract]   [Full Text] [Related]  

  • 10. [The kinin and plasmin systems of the blood serum and cerebro- spinal fluid in patients with multiple sclerosis and schizophrenia].
    Vilkov GA; Martirosian VV; Trapezontseva RA; Kozlova LS; Ellanskiĭ IuIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):23-7. PubMed ID: 2477972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems.
    Friberger P
    Scand J Clin Lab Invest Suppl; 1982; 162():1-298. PubMed ID: 6221396
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of plasmin on kallikreinogen].
    Andreenko GV; Suvorov AV
    Biokhimiia; 1976 Mar; 41(3):557-61. PubMed ID: 132197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effects of p-carbethoxyphenyl epsilon-guanidinocaproate and trasylol on the esterolysis by various kallikreins, plasmin and plasmin-alpha 2-macroglobulin complex.
    Tamura Y; Ishimaru K; Mori H; Hirado M; Fujii S
    Tokushima J Exp Med; 1979 Dec; 26(3-4):81-3. PubMed ID: 94710
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of water-insoluble derivatives of the trypsin-kallikrein inhibitor for the isolation of kallikrein and plasmin].
    Fritz H; Brey B; Schmal A; Werle E
    Hoppe Seylers Z Physiol Chem; 1969 May; 350(5):617-25. PubMed ID: 4239805
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
    Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
    Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intensity of kininergic reactions of the cardiovascular system in different activities of the plasma kallikrein-kinin system].
    Kiselev VI; Lebedev NM
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):386-90. PubMed ID: 6552214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between the activity of the kallikrein, plasmin and thrombin systems of the blood during intense physical exertion].
    Gomazkov OA; Komissarova NV; Lantsberg LA
    Biull Eksp Biol Med; 1977 Nov; 84(11):521-3. PubMed ID: 145251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rationale for the therapeutic action of aprotinin.
    Haberland G; McConn R
    Fed Proc; 1979 Dec; 38(13):2760-7. PubMed ID: 159836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior of the kallikrein inhibitor against enzymes, 3. Behavior of the kallikrein inhibitor from bovine lung against proteases].
    Kraut H; Bhargava N
    Hoppe Seylers Z Physiol Chem; 1967 Nov; 348(11):1498-9. PubMed ID: 4231141
    [No Abstract]   [Full Text] [Related]  

  • 20. [Study of the kinin-forming and kinin-splitting enzymes in the blood in patients with allergic rhinitis].
    Veremeenko KN; Lositskaia VM; Belunova TI
    Zh Ushn Nos Gorl Bolezn; 1974; (6):36-41. PubMed ID: 4446796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.